Selective neuron loss in the paraventricular nucleus of hypothalamus in patients suffering from major depression and bipolar disorder

Journal of Neuropathology and Experimental Neurology

Volumn 64, Issue 3, 2005, Pages 224-229

  Manaye, Kebreten F ^a,d   Lei, D Liang ^a   Tizabi, Yousef ^a   Dávila García, Martha I ^a   Mouton, Peter R ^b   Kelly, Peter H ^c  

^a HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b Stereology Resource Center   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

^d Adams Bldg ^*  (United States)

Author keywords

Bipolar depression; Major depression; Paraventricular nucleus; Supraoptic nucleus; Unbiased stereology

Indexed keywords

ANALYSIS OF VARIANCE; ANTERIOR HYPOTHALAMUS; ARTICLE; AUTOPSY; BIPOLAR DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; DIENCEPHALON; FEMALE; HISTOLOGY; HUMAN; MAJOR DEPRESSION; MALE; NERVE CELL DEGENERATION; NISSL STAINING; PRIORITY JOURNAL; STEREOLOGY; SUPRAOPTIC NUCLEUS;

EID: 15244344775     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/64.3.224     Document Type: Article

References (41)

1. Coffey CE, Figiel GS, Djang WT, et al. Leukoencephalopathy in elderly depressed patients referred for ECT. Biol Psychiatry 1988;24:143-61
2. Krishnan KR, Goli V, Ellinwood EH, et al. Leukoencephalopathy in patients diagnosed as major depressive. Biol Psychiatry 1988;23:519-22
3. Krishnan KR, McDonald WM, Escalona PR, et al. Magnetic resonance imaging of the caudate nuclei in depression: Preliminary observations. Arch Gen Psychiatry 1992;49:553-7
4. Benes FM, Vincent SL, Todtenkop FM. The density of pyramidal and nonpyramidal neurons in anterior cingulate cortex of schizophrenic and bipolar subjects. Biol Psychiatry 2001;50:395-406
5. Rajkowska G, Miguel-Hidalgo JJ, Wei J, et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry 1999;45:1085-98
6. Duman RS, Heninger GR, Nestler EJ. A molecular and cellular theory of depression. Arch Gen Psychiatry 1997;54:597-606
7. Sheline YI, Black KJ, Lin DY, et al. Stereological MRI volumetry of the frontal lobe. Psychiatry Res 1996;67:203-14
8. Sheline YI, GadoMH, Price JL. Amygdala core nuclei volumes are decreased in recurrent major depression. NeuroReport 1998;9:2023-28
9. Sheline YI, Gado MH, Kraemer HC. Untreated depression and hippocampal volume loss. Am J Psychiatry 2003;160:1516-18
10. Lucassen PJ, Muller MB, Holsboer F, et al. Hippocampal apoptosis in major depression is a minor event and absent from subareas at risk for glucocorticotd overexposure. Am J Pathol 2001;158:453-68
11. Bowley MP, Drevets WC, Ongur D, et al. Low glial numbers in the amygdala in major depressive disorder. Biol Psychiatry 2002;52:404-12
12. Chen G, Rajkowska G, Du F, et al. Enhancement of hippocampal neurogenesis by lithium. J Neurochem 2000;75:1729-34
13. Duman RS. Depression: A case of neuronal life and death? Biol Psychiatry 2004;56:140-45
14. Barden N. Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression. J Psychiatry Neurosci 2004;29:185-93
15. Ehlert U, Gaab J, Heinrichs M. Psychoneuroendocrinological contributions to the etiology of depression posttraumatic stress disorder and stress-related bodily disorders: The role of the hypothalamus-pituitary-adrenal axis. Biol Psychol 2001;57:141-52
16. Sterio DC. The unbiased estimation of number and sizes of arbitrary particles using the dissector. J Microsc 1984;134:127-36
17. Mouton PR, Pakkenberg B, Gundersen HJ, et al. Absolute number and size of pigmented locus coeruleus neurons in young and aged individuals. J Chem Neuroanat 1994;7:185-90
18. Manaye KF, Zweig R, Wu D, et al. Quantification of cholinergic and select noncholinergic mesopontine neuronal populations in the human brain. Neuroscience 1999;89:759-70
19. Mouton PR. Principles and Practices of Unbiased Stereology: An Introduction for Bioscientists. Baltimore: Johns Hopkins University Press, 2002
20. Lei D-L, Long JM, Hengemihle J, et al. Effects of estrogen and raloxifene on neuroglia number and morphology in the hippocampus of aged female mice. Neuroscience 2003;121:659-66
21. Ongur D, An X, Price JL. Prefrontal cortical projections to the hypothalamus in macaque monkeys. J Comp Neurol 1998;401:480-505
22. Rajkowska G. Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol Psychiatry 2000;48:766-77
23. Swaab DF, Fliers E, Hoogendijk WJ, et al. Interaction of prefrontal cortical and hypothalamic systems in the pathogenesis of depression. Prog Brain Res 2000;126:369-96
24. Goudsmit E, Hofman MA, Fliers E, et al. The supraoptic and paraventricular nuclei of the human hypothalamus in relation to sex age and Alzheimer's disease. Neurobiol Aging 1990;11:529-36
25. Harrison PJ. The neuropathology of primary mood disorder. Brain 2002;125:1428-49
26. Harding AJ, Ng JL, Halliday GM, et al. Comparison of the number of vasopressin-producing hypothalamic neurons in rats and humans. J Neuroendocrinol 1995;7:629-36
27. Bernstein HG, Stanarius A, Baumann B, et al. Nitric oxide synthase-containing neurons in the human hypothalamus: Reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics. Neuroscience 1998;83:867-75
28. Morton A. A quantitative analysis of the normal neuron population of the hypothalamic magnocellular nuclei in man and of their projections to the neurohypophysis. J Comp Neurol 1969;136:143-57
29. Koutcherov Y, Mai JK, Ashwell KWS, et al. Organization of the human paraventricular hypothalamic nucleus. J Comp Neurol 2000;423:299-318
30. Vogels OJ, Broere CA, Nieuwenhuys R. Neuronal hypertrophy in the human supraoptic and paraventricular nucleus in aging and Alzheimer's disease. Neurosci Lett 1990;109:62-67
31. Rasmussen AT. Effects of hypophysectomy and hypophysial stalk resection on the hypothalamic nuclei of animals and man. A Res Nerv Ment Dis 1940;20:269
32. Swanson LW, Sawchenko PE. Hypothalamic integration: Organization of the paraventricular and supraoptic nuclei. Ann Rev Neurosci 1983;6:269-324
33. Bernstein HG, Heinemann A, Krell D, et al. Further immunohistochemical evidence for impaired NO signaling in the hypothalamus of depressed patients. Ann NY Acad Sci 2002;973:91-93
34. Raadsheer FC, Hoogendijk WJ, Stam FC, et al. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology 1994;60:436-44
35. Purba JS, Hoogendijk WJ, Hofman MA, et al. Increased number of vasopressin-1 and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression. Arch Gen Psychiatry 1996;53:137-43
36. Urban IJA, Burbach JP. Advances in Brain Vasopressin. Amsterdam: Elsevier, 2004
37. Nakase S, Kitayama I, Soya H, et al. Increased expression of magnocellular arginine vasopressin mRNA in paraventricular nucleus of stress-induced depression-model rats. Life Sci 1998;63:23-31
38. Wigger A, Sanchez MM, Mathys KC, et al. Alterations in central neuropeptide expression release and receptor binding in rats bred for high anxiety: Critical role of vasopressin. Neuropsychopharmacology 2004;29:1-14
39. Brown MR, Fisher LA, Sawchenko PE, et al. Biological effects of cysteamine: Relationship to somatostatin depletion. Regul Pept 1983;5:163-79
40. Bartanusz V, Muller D, Gaillard RC, et al. Local gamma-aminobutyric acid and glutamate circuit control of hypophyseotrophic corticotropin-releasing factor neuron activity in the paraventricular nucleus of the hypothalamus. Eur J Neurosci 2004;19:777-82
41. Kovacs KJ, Miklos IH, Bali B. GABAergic mechanisms constraining the activity of the hypothalamo-pituitary-adrenocortical axis. Ann NY Acad Sci 2004;1018:466-76